
Anal cancer is a rare type of cancer that forms in the tissues of the anus or anal canal. About 80% of anal cancers are diagnosed in individuals who are over age 60. Before age 35, anal cancers are common among men; however, after age 50, it is more commonly seen among women.
Anal cancers are different from colorectal cancers, which are relatively more common. Human papillomavirus (HPV) infection in the anal canal, which may lead to genital warts, is considered to be a major risk factor for anal cancer development. Receptive anal intercourse is also strongly linked to anal cancer incidence.
Also, immunocompromised patients, i.e., those with HIV and other diseases, show a higher risk of developing anal cancer with a poor prognosis.
Often, the first sign of anal cancer is bleeding. Another common symptom is the itching at the anal opening; however, individuals tend to attribute this symptom to haemorrhoids. This may lead to a delayed diagnosis of anal cancer. Following are other symptoms that are associated with anal cancer:
The exact cause of anal cancer is unknown. Nevertheless, a few risk factors have been identified for anal cancers.
Anal cancer is closely associated with the sexually transmitted infection caused by human papillomavirus (HPV). Chronic HPV infection is considered to be the biggest risk factor for anal cancers.
Following are various other risk factors that are associated with anal cancer development:
There are various tests available to detect and diagnose anal cancer:
a. Anal Canal and Rectum Examination: During this procedure, the doctor inserts a gloved, lubricated finger into the rectum to look for any abnormal growths.
b. Visual Inspection of the Anal Canal and Rectum: An anoscope, a short, lighted tube, is inserted into the anal canal and rectum to find any abnormalities.
c. Ultrasound: Ultrasound scan of the anal canal helps in tumour detection, determining tumour size along with the depth of invasion. During the procedure, a probe is inserted into the anal canal and rectum, which emits high-energy sound waves that are captured and converted to images. These images will provide information on any abnormalities present.
d. Biopsy: If any abnormality is found, a small sample of tissue may be excised and sent to a laboratory for further examination.
Once the above tests confirm the diagnosis, the doctor may recommend additional tests for cancer staging. These tests help in finding out if cancer has spread to lymph nodes and other critical organs in the body.
PET/CT scan and MRI scan are the commonly recommended tests for staging purposes.
Before devising treatment plans for anal cancers, multiple factors such as the stage of the disease, the tumour grade, the patient’s age, the overall condition of the patient and their preferences are taken into account. Various treatment options available for anal cancer include radiation therapy, chemotherapy and surgery. It has been found that the multimodal approach will have a positive impact on the treatment response and clinical outcomes among anal cancer patients.
a. Radiation Therapy: During radiation therapy, high-energy radiation beams are delivered to the tumour to kill the cancer cells. This treatment destroys the DNA structure in cancer cells and thereby kills them. Radiation can be delivered using an external radiation source (linear accelerators) or an internal radiation source (brachytherapy). Radiotherapy planning is done based on the stage, size and the exact location of the tumour.
b. Chemotherapy: During chemotherapy, potent chemo drugs are administered into the body to kill or destroy cancer cells throughout the body. Chemotherapy can be administered orally, intravenously or intramuscularly. As a systemic therapy, it destroys or stops the cancer cells from dividing throughout the body. Among anal cancer patients, chemotherapy is administered in different situations:
c. Surgery: Although not the main line of treatment for anal cancer, surgery is considered in a few cases based on the stage of the disease.
It is important to note that early detection improves the chances of positive clinical outcomes among patients and supports a better quality of life.
An untreated anal cancer progresses to advanced conditions and spreads to other critical organs. This causes many health complications and may lead to poor survival rates.
Early detection, therefore, plays a significant role in cancer management. It is important to not ignore any symptoms and take appropriate actions whenever necessary.
There are many measures that can reduce your anal cancer risk. Some of the measures include practising safe sex habits, receiving HPV vaccination, quitting tobacco and cultivating a healthier lifestyle.
Side effects vary from patient to patient. Some may experience very mild side effects, while some may experience moderate to severe side effects.
The potential side effects associated with anal cancer treatment include diarrhoea, anal irritation and pain, hampered bowel movements, discomfort during bowel movements, tiredness, nausea, constipation, skin changes, low blood cell count, loss of appetite, hair loss, etc.
In many cases, haemorrhoids and cancer show the same symptoms, due to which the patients tend to ignore the symptoms. This may eventually lead to delayed diagnosis and poor clinical outcomes.
Rectal pain, itching and bleeding are the main signs of anal cancer, and they are not to be ignored.
In general, any abnormalities associated with your health should be presented to your doctor immediately, as this supports early detection and timely treatment for any health issues.
Copyright © 2023 by HCG CCK Cancer Centre.